---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-020807"
form_type: "8-K"
ticker: "ADVB"
cik: "0001941029"
company_name: "Advanced Biomed Inc."
filed_at: "2026-02-26T23:59:59+00:00"
generated_at: "2026-05-15T23:49:03.318936+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Advanced Biomed announces 1-for-20 reverse stock split to regain Nasdaq compliance

## Summary
- Reverse split effective Feb 20, 2026; every 20 shares become 1 share, par value unchanged $0.001.
- Outstanding shares reduced from 27,290,710 to approx 1,364,536; authorized shares unchanged.
- New CUSIP 00752P203; stock continues trading under symbol ADVB; no fractional shares issued.
- Split aims to meet Nasdaq minimum bid price of $1.00 per share.
- Stockholder approval obtained via written consent on Jan 12, 2026; board set ratio Jan 30.

## SEC filing metadata
- accession: 0001213900-26-020807
- form_type: 8-K
- ticker: ADVB
- cik: 0001941029
- company_name: Advanced Biomed Inc.
- filed_at: 2026-02-26T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1941029/000121390026020807/0001213900-26-020807-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1941029/000121390026020807/ea0278448-8k_advanced.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-020807
- JSON: https://secwatch.observer/filing/0001213900-26-020807.json
- Plain text: https://secwatch.observer/filing/0001213900-26-020807.txt

## Key facts
- Governance Changes
  Advanced Biomed Inc.: Amended certificate of incorporation to effect a 1-for-20 reverse stock split, effective February 20, 2026, with no change to authorized shares or par value (effective 2026-02-20).
  - Change: charter amendment
  - Effective: 2026-02-20
  source text: On February 3, 2026, Advanced Biomed Inc. (the “Company”) filed with the Secretary of State of the State of Nevada an amendment (the “Certificate of Amendment”) to its amended and restated certificate of incorporation, as amended (the “Certificate of Incorporation”), to effect a reverse stock split of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a ratio of 1-for-20 (the “Reverse Stock Split”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1941029/000121390026020807/0001213900-26-020807-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.